<DOC>
	<DOCNO>NCT01073540</DOCNO>
	<brief_summary>A single dose , two treatment ( two cephalexin suspension brand ) , two sequence , cross-over design use washout 7 day two study period . Treatment group balance number healthy volunteer randomly ( two stratum : male female ) assign study drug administration sequence .</brief_summary>
	<brief_title>Cross-over Study Prove Bioequivalence Between Two Brands Cefalexin Suspension</brief_title>
	<detailed_description />
	<mesh_term>Cephalexin</mesh_term>
	<criteria>Healthy male female volunteer age 18 55 year old normal vital sign , electrocardiogram ( ECG ) , blood chemistry , liver function profile urinalysis History illnesses organic abnormality could affect result study History tobacco alcohol abuse regular use recreational therapeutic drug Subjects take medication within 14 day elimination period le 7 halflives ( whichever long ) study startup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>